Crosby, Katherine
Harvard University · Massachusetts General Hospital · Dana-Farber Cancer Institute · Dana-Farber/Harvard Cancer Center · Cell Signaling Technology (United States)
2 papers on CoChat
Most cited papers
- Verified
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Engelman, J. A., Chen, L., Tan, X., Crosby, K., Guimaraes, A. R., Upadhyay, R., Maira, M., McNamara, K., Perera, S. A., Song, Y., et al. (2008) · Nature Medicine
PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase Signaling
Cited by 1,330
- Verified
An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation
Schoeberl, B., Faber, A. C., Li, D., Liang, M.-C., Crosby, K., Onsum, M., Burenkova, O., Pace, E., Walton, Z., Nie, L., et al. (2010) · Cancer Research
HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations
Cited by 264
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free